This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MRI Interventions And Brainlab Launch European Commercialization Effort With First ClearPoint Case In Europe

MEMPHIS, Tenn. and MUNICH, Sept. 19, 2012 /PRNewswire/ -- MRI Interventions, Inc. (OTCBB:MRIC) and Brainlab AG announced today that Prof. Stephan Chabardes at Universite Joseph Fourier (UJF) Hospital in Grenoble, France has performed the first two cases in Europe with the ClearPoint ® Neuro Intervention System.  Prof. Chabardes used the ClearPoint system to assist with the implantation of deep brain stimulation (DBS) leads in two patients suffering from Parkinson's disease.  In addition to being the first ClearPoint commercial cases in Europe, the cases carried the historical significance of being performed at the location where DBS treatment was originally developed.

DBS therapy is a reversible and adjustable treatment for a variety of neurological disorders by which an electronic lead is placed at a targeted location inside the brain and connected to a pulse generator that is implanted under the skin in the patient's chest area.  The pulse generator is set to a customized frequency, and it delivers small electrical pulses to the target area of the brain.  The device, which some refer to as a "pacemaker for the brain," is used to suppress disabling symptoms associated with the particular neurological disorder being treated. Since its inception 25 years ago, DBS has become an important and established treatment that has improved the quality of life for over 80,000 people.

The traditional surgical technique for implanting DBS leads has been performed without intra-procedural visualization, meaning that the surgeon cannot see the neurological target and surgical devices inside the brain while the procedure is being performed.  By contrast, the next generation ClearPoint system provides surgeons with direct, real-time visualization of the patient's anatomy and the surgical devices throughout the procedure.  Using the ClearPoint system, the surgeon sees and selects the neurological target, aims the ClearPoint targeting device, and watches via magnetic resonance imaging (MRI) as the surgical tool is advanced to the target. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs